EuroIntervention PCRonline - Connecting with the community

Just accepted article

Clinical outcomes with the STENTYS Self-Apposing coronary stent in patients presenting with ST-segment elevation myocardial infarction 2-year insights from the APPOSTION III (A Post-Market registry to assess the STENTYS self-exPanding COronary Stent In AcuTe MyocardIal InfarctiON) registry

Disclaimer:

As a public service to our readership, this article - peer reviewed by the Editors of EuroIntervention - has been published immediately upon acceptance as it was received. The content of this article is the sole responsibility of the authors, and not that of the journal or its publishers. To read the full content of this article, please download the PDF.

Sign in to download the full article

1. Academic Medical Center Amsterdam, NETHERLANDS; 2. Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; 3. Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands; 4. Albert Schweitzer Ziekenhuis, Dordrecht, The Netherlands; 5. Erasmus Medical Center, Rotterdam, The Netherlands; 6. Cologne Cardiovascular and Chest Center, Cologne, Germany; 7. SLK Kliniken, Heilbronn, Germany; 8. Ospedale Ferrarotto, Catania, Italy; 9. Sorbonne Université Paris 6 - ACTION Study Group - CHU La Pitié-Salpêtrière (AP-HP); Paris, France; 10. Sorbonne Université Paris 6 - ACTION Study Group - CHU La Pitié-Salpêtrière (AP-HP); Paris, France; 11. STENTYS S.A., Paris, France; 12. Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; 13. Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands; 14. Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; 15. Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

Abstract

Aims: The APPOSITION III registry evaluated the feasibility and performance of the STENTYS self-apposing stent in a ST-segment elevation myocardial infarction (STEMI) population. This novel self-apposing stent device lowers stent strut malapposition rates and therefore bears the potential to prevent stent undersizing during primary percutaneous coronary intervention (PCI) in STEMI patients. Up to date, no long-term data is available using this device in the setting of STEMI. We aimed to evaluate long-term clinical outcomes of the APPOSITION III registry.

Methods and results: This was an interna…

– OR –